Functional Genetic Screening Services for Tumor Metabolism

With our comprehensive metabolic profiling technologies, Creative Biolabs has developed a first-class platform for functional genetic screening for tumor metabolism.

Introduction of Functional Genetic Screening for Tumor Metabolism

There are complex interactions between cancer and metabolism (see Fig.1). For tumor metabolism, the functional screening of metabolic genes and enzymes plays a critical role in early cancer diagnosis, treatment strategy, and therapeutic research. The technologies based on CRISPR/Cas9, RNAi, and small molecule inhibitors have been successfully used to identify cancer metabolic phenotypes and metabolic dependencies.

Fig.1 Cancer and metabolism interactions.¹

Functional Genetic Screening for Tumor Metabolism Services at Creative Biolabs

Creative Biolabs provides multi-dimensional and comprehensive technologies to explore the functional characterization of metabolic genes and enzymes for cancer and metabolic diseases.

• CRISPR/Cas9-based Metabolic Gene Functional Assessment
• RNAi-based Metabolic Gene Functional Assessment
• Small Molecule Inhibitor-based Metabolic Enzyme Functional Assessment

Features & Benefits

• Various cell lines and animal models.
• High efficiency of genetic transfection.
• High-throughput and automated screening.
• Professional data analysis and visual interpretation.

Creative Biolabs is a leading company in providing a one-stop service for functional genetic screening with an expert team and powerful technologies. We are pleased to provide professional consultations before, during, and after the project. Please contact us for detailed information.

Reference

1. Schmidt, Daniel R., et al. "Metabolomics in cancer research and emerging applications in clinical oncology." CA: a cancer journal for clinicians 71.4 (2021): 333-358.

For Research Use Only | Not For Clinical Use